OK Biotech Co., Ltd. primarily developes, manufactures and markets blood glucose monitoring system, meters and related supplies for diabetes patients. The company also manufacturesskin care products, cosmetics, LED and other battery-ap plication products.

The Company Was Invited To Participate In The
Online Institutional Investor Conference By Fubon
Securities

The Company’S Sustainable Development Committee
And List Of New Members

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Ok Biotech (4155 TT)

The Company Was Invited To Participate In The Online Institutional Investor Conference By Fubon Securities

The Company’S Sustainable Development Committee And List Of New Members

The Board Of Directors Of The Company Approved The Consolidated Financial Statements For The Third Quarter Of 2024

Announcement Of The Company’S Third Quarter 2024 Consolidated Financial Report Board Meeting Date

The Company Withdraws The Issued New Shares With Restricted Employee Rights And Handles Cancellation And Capital Reduction.

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)